Date | Name | Shares | Transaction | Value |
Apr 2, 2025
| Gerhard F. Burbach Director |
680
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 2, 2025
| John M. Richardson Director |
270
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 2, 2025
| Nicole W. Piasecki Director |
24
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 2, 2025
| Leland D. Melvin Director |
165
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 2, 2025
| Kenneth J. Krieg Director |
1,290
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 2, 2025
| Jan A. Bertsch Director |
2,061
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 2, 2025
| Robert L. Nardelli Director |
2,421
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 2, 2025
| James M. Jaska Director |
990
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 7, 2025
| Robert L. Duffy SVP and Chief Admin. Officer |
3,206
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $104.03 per share |
333,520.18
|
Mar 3, 2025
| Robb A. LeMasters SVP & Chief Financial Officer |
1,162
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 3, 2025
| Robb A. LeMasters SVP & Chief Financial Officer |
8,973
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Robb A. LeMasters SVP & Chief Financial Officer |
2,343
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Robb A. LeMasters SVP & Chief Financial Officer |
40,369
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $106.64 per share |
4,304,950.16
|
Mar 3, 2025
| Robert L. Duffy SVP and Chief Admin. Officer |
9,206
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $106.64 per share |
981,727.84
|
Mar 3, 2025
| Rex D. Geveden President and CEO; Director |
4,259
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 3, 2025
| Rex D. Geveden President and CEO; Director |
39,483
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Omar Meguid SVP and Chief Digital Officer |
432
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 3, 2025
| Rex D. Geveden President and CEO; Director |
220,837
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $106.64 per share |
23,550,057.68
|
Mar 3, 2025
| Rex D. Geveden President and CEO; Director |
222,756
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 3, 2025
| Rex D. Geveden President and CEO; Director |
218,218
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $107.91 per share |
23,547,904.38
|